Curriculum Vitae
Name: Chih-Chin Kao (高治圻)
Gender: Male
Date of birth: Nov 17, 1980
Place of birth: Taipei, Taiwan
Office Address:
Division of Nephrology, Department of Internal Medicine
Taipei Medical University Hospital
No.252, Wu Hsing Street
Taipei city 110, Taiwan
Telephone: +886-2-2737-2181 ext. 3909
Fax: +886-2-2736-3051
E-mail: salmonkao@gmail.com
Education
1999-2006 M.D., National Yang Ming University
2013- A current student at Graduate Institute of Clinical Medicine,
College of Medicine, Taipei Medical University
Residency and Fellowship Training
2007-2008 Resident, Department of Internal Medicine, Mackay Memorial Hospital
2008-2010 Resident, Department of Internal Medicine, National Taiwan University Hospital
2010-2012 Chief Resident, Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital
2012- Attending physician, Division of Nephrology, Department of Internal Medicine, Taipei Medical University Hospital
Board Certification
2006 Board of Medicine, Taiwan
2010 Specialty Board of Internal Medicine, Taiwan Society of Internal Medicine
2012 Specialty Board of Nephrology, Taiwan Society of Nephrology
2014 Member of Taiwan Society of Critical Care Medicine
Awards
2014 Young Investigator Fellowships of the Asian Pacific Society of Hypertension
(10th APCH, Asian Pacific Congress of Hypertension)
2014 優良教師獎 Taipei medical university hospital
2014 The Best Visiting Staff of Internal Medicine, Taipei medical university hospital
Publications
1. Kao CC, Wu CH, Lin YH, Chang CC, Chen HH, Wu MS, Wu VC, Wu KD, TAIPAI Study Group. Risk of ischemic stroke in primary aldosteronism patients. Clin Chim Acta. 2014 Aug 11. pii: S0009-8981(14)00348-9. In press
2. Kao CC, Wu VC, Kuo CC, Lin YH, Hu YH, Tsai YC, Wu CH, Wu KD. Delayed diagnosis of primary aldosteronism in patients with autosomal dominant polycystic kidney diseases. J Renin Angiotensin Aldosterone Syst. 2013 Jun; 14(2): 167-73
3. Chou YH, Lien YC, Hu FC, Lin WC, Kao CC, Lai CF, Chiang WC, Lin SL, Tsai TJ, Wu KD, Chen YM. Clinical Outcomes and Predictors for ESRD and Mortality in Primary GN. Clin J Am Soc Nephrol. 2012 Sep;7(9):1401-8.
4. Wu VC, Hu YH, Wu CH, Kao CC, Wang CY, Yang WS, Lee HH, Chang YS, Lin YH, Wang SM, Chen L, Wu KD; TAIPAI Study Group. Development and Validation of Algorithms of Locating Patients with Primary Aldosteronism Using Administrative Data. J Clin Epidemiol. 2014 Jul 14. pii: S0895-4356(14)00205-4
5. Daw-Yang Hwang, Shu-Chen Chien, Yu-Wen Hsu, Chih-Chin Kao, Shih-Ying Cheng, Hui-Chen Lu, Mai-Szu Wu, and Jer-Ming Chang. Genetic Polymorphisms of ORAI1 and Chronic Kidney Disease in Taiwanese Population. Biomed Res Int. 2014;2014:290863. In press
6. Chih-Chin Kao, Mai-Szu Wu. Renoprotective effect of pentoxifylline in advanced chronic kidney disease. J Formos Med Assoc. 2014 Jun 26. pii: S0929-6646(14)00176-4. In press
7. Kao CC, Wu VC, Sun HY, Wu CH; The NSARF Group. Paradoxical cryptococcal immune reconstitution inflammatory syndrome in advanced chronic kidney disease. Int Urol Nephrol. 2013 Oct; 45(5): 1505-9
8. Kao CC, Chiang CK, Huang JW. Micrococcus species-related peritonitis in patients receiving peritoneal dialysis. Int Urol Nephrol. 2014 Jan; 46(1): 261-4
9. Kao CC, Tsai YC, Chiang WC, Mao TL, Kao TW. Ileum and colon perforation following peritoneal dialysis-related peritonitis and high-dose calcium polystyrene sulfonate. J Formos Med Assoc. 2013, in press
10. Chao CT, Kao CC, Lee SY, Ho SJ, Jhuang YJ, Li LH, Kao TW. Renal cell carcinoma with secondary hemophagocytic syndrome: A case report. Can Urol Assoc J. 2012; 6(2): E64-6
11. Yang CC, Kao CC. Cardiovascular diseases and the risk of venous thromboembolism: a hospital-based case-control study. J Chin Med Assoc. 2007; 70(3): 103-9
會議發表:
1. The Hemodynamic effects during Sustained low-efficiency dialysis versus Continuous veno-venous hemofiltration for patients with intracranial hypertension in a cross over study. The 17th CRRT (Continuous Renal Replacement Therapies) conference, 2012 (Poster)
2. Long-Term Risk of Dementia Following Acute Kidney Injury: A Population-Based Study. ISN World Congress of Nephrology, 2013 (Poster)
3. Predictors of Insulin Resistance and the Impact of Vitamin D Supplement in Chronic Hemodialysis (HD) Patients. The 51st ERA-EDTA Congress, 2014 (Poster)
4. Risk of hepatitis after acarbose therapy in advanced chronic kidney disease patients: A Population-Based Study. ISN World Congress of Nephrology, 2015 (Poster)